DD ACE gene polymorphism is associated with increased coronary artery endothelial dysfunction: The PREFACE trial

Heart

Volumn 89, Issue 5, 2003, Pages 557-558

  Mulder, Han J G H ^a   Van Geel, P P ^b   Schalij, M J ^a   Van Gilst, W H ^b   Zwinderman, A H ^c   Bruschke, A V G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CELL FUNCTION; CORONARY ARTERY DISEASE; ENDOTHELIUM LESION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL;

EID: 0242668430     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.5.557     Document Type: Article

References (4)

1. Mulder HJGH, Schalij MJ, Kauer B, et al. Pravastatin and endothelium dependent vasomotion after percutaneous transluminal coronary angioplasty (PTCA): the PREFACE (pravastatin related effects following angioplasty on coronary endothelium) trial. Heart 2001;86:533-9.
2. Schunkert H, Hense HW, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-8.
3. Perticone F, Ceravolo R, Maio R, et al. Angiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients. Hypertension 1998;31:900-5.
4. Butler R, Morris AD, Burchell B, et al. DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension 1999;33:1164-8.